Cover Image
市場調查報告書

美國及歐洲的糖尿病診斷市場分析

Analysis of the US and European Diabetes Diagnostics Market

出版商 Frost & Sullivan 商品編碼 335085
出版日期 內容資訊 英文 159 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國及歐洲的糖尿病診斷市場分析 Analysis of the US and European Diabetes Diagnostics Market
出版日期: 2015年07月01日 內容資訊: 英文 159 Pages
簡介

美國及歐洲的糖尿病診斷市場多年處於成熟階段,兩個地區都因為糖尿病高罹患率而持續成長。非侵入性技術帶來正確且高感度的結果並減少患者的疼痛,預計今後大幅成長。就地檢驗美國依然穩定成長,由於效率和成本效益、可用性預計急速發展。

本報告提供歐洲及美國的糖尿病診斷市場概要與主要市場區隔、各種地區的各市場區隔收益預測,及值得注意的企業等彙整資料。

第1章 摘要整理

第2章 市場概要

  • 糖尿病的簡介
  • 市場概要
  • 市場區隔
  • 市場區隔生命週期分析
  • 競爭市場區隔分析
  • 未來的醫療趨勢

第3章 競爭劇本

  • 競爭環境
  • 新的市場機會

第4章 全體市場分析

  • 評估
  • 假設
  • 收益預測
  • 市場區隔概要
  • 各市場區隔收益預測
  • 收益預測相關考察

第5章 美國市場

  • 推動市場的要素
  • 阻礙市場的要素
  • 評估
  • 美國市場收益預測
  • 市場區隔概要
  • 各市場區隔收益預測
  • 收益預測相關考察

第6章 美國的SMBG (血糖時間監測) 市場區隔

  • 評估
  • 收益預測
  • 各市場區隔收益預測
  • 收益預測相關考察
  • 市場佔有率分析

第7章 美國的POCT (就地檢驗) 市場區隔

  • 評估
  • 收益預測
  • 各市場區隔收益預測
  • 收益預測相關考察
  • 市場佔有率分析

第8章 美國的實驗室檢驗市場區隔

  • 評估
  • 收益預測
  • 各市場區隔收益預測
  • 收益預測相關考察
  • 市場佔有率分析
  • 實驗室檢驗趨勢
  • 實驗室檢驗間比較

第9章 歐洲分析

  • 評估
  • 各地位收益預測
  • 收益預測相關考察
  • 市場區隔概要

第10章 歐洲的SMBG市場區隔

  • 評估
  • 收益預測
  • 各市場區隔收益預測
  • 收益預測相關考察
  • 市場佔有率分析

第11章 歐洲的POCT市場區隔

  • 評估
  • 收益預測
  • 各市場區隔收益預測
  • 收益預測相關考察
  • 市場佔有率分析

第12章 歐洲的實驗室檢驗市場區隔

  • 評估
  • 收益預測
  • 各市場區隔收益預測
  • 收益預測相關考察
  • 市場佔有率分析
  • 實驗室檢驗趨勢
  • 實驗室檢驗間比較

第13章 歐洲的各地區分析

第14章 值得注意的企業

  • HemoCue
  • NovioSense
  • Miraculins

第15章 最後

第16章 附錄

圖表

目錄
Product Code: NF12-01-00-00-00

Constricting Reimbursement Policies Restrain Market Growth

The diabetes diagnostics markets in the United States and Europe have been in a mature stage for many years. Growth is sustained due to the high prevalence of diabetes in both regions. The segments covered in the study are self-monitoring of blood glucose (SMBG), point-of-care testing (POCT), and lab-based HbA1c testing. The emerging market of non-invasive technologies is disrupting this market space as it reduces patient pain points while providing accurate and sensitive results. Due to more hospital-centric care in the EU region, the POCT segment here experiences stronger growth than in the United States. POCT has the potential to grow the fastest due to its efficient, cost-effective solution and increasing adoption by physicians.

Key Questions this Study will Answer

  • What is the diabetes diagnostics market scenario in Europe and the United States?
  • How are the large exiting participants going to change this market?
  • Which are the major market segments, and what are the important trends that could affect market direction?
  • Who are the key market participants involved in each segment? What are their best practices in this market?
  • What are the key changes in the diabetes policy system of different regions in Europe and the United States and how will they affect the market in the future?
  • What is the future of the diabetes diagnostics market in Europe and the United States, and what should market participants do to succeed?

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

  • 1. Key Findings
  • 2. Key Findings (continued)
  • 3. Key Findings (continued)
  • 4. Scope and Segmentation
  • 5. Key Questions this Study will Answer
  • 6. Measurements
  • 7. CEO's Perspective
  • 8. Key Companies to Watch
  • 9. Executive Summary-3 Big Predictions

2. MARKET OVERVIEW

Market Overview

  • 1. Introduction to Diabetes
  • 2. Market Overview
  • 3. Market Segmentation
  • 4. Segment Life Cycle Analysis
  • 5. Market Segmentation
  • 6. Competitive Segment Analysis
  • 7. Defining Healthcare Trends in the Future

3. COMPETITIVE PLAYBOOK

Competitive Playbook

  • 1. Diabetes Diagnostics Market-Competitive Landscape
  • 2. New Market Opportunities
  • 3. New Market Opportunities (continued)
  • 4. Competitive Analysis
  • 5. Competitive Analysis (continued)
  • 6. Competitive Analysis (continued)
  • 7. Competitive Analysis (continued)
  • 8. Competitive Analysis (continued)

4. TOTAL MARKET ANALYSIS

Total Market Analysis

  • 1. Measurements
  • 2. Forecast Assumptions
  • 3. Revenue Forecast
  • 4. Segment Overview
  • 5. Revenue Forecast by Segment
  • 6. Revenue Forecast Discussion

5. US ANALYSIS

US Analysis

  • 1. Market Drivers
  • 2. Drivers Explained
  • 3. Drivers Explained (continued)
  • 4. Market Restraints
  • 5. Restraints Explained
  • 6. Measurements
  • 7. US Revenue Forecast
  • 8. Segment Overview
  • 9. Revenue Forecast by Segment
  • 10. Revenue Forecast Discussion

6. US SMBG SEGMENT

US SMBG Segment

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast by Segment
  • 4. Revenue Forecast Discussion
  • 5. Market Share Analysis
  • 6. Market Share Analysis (continued)

7. US POCT SEGMENT

US POCT Segment

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast by Segment
  • 4. Revenue Forecast Discussion
  • 5. Market Share Analysis

8. US LAB-BASED TESTING SEGMENT

US Lab-based Testing Segment

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast Discussion
  • 4. Market Share Analysis
  • 5. Lab-based Testing Trends
  • 6. Comparison of Lab-based Tests
  • 7. Comparison of Lab-based Tests (continued)

9. EUROPE ANALYSIS

Europe Analysis

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast by Region
  • 4. Revenue Forecast Discussion
  • 5. Segment Overview

10. EUROPE SMBG SEGMENT

Europe SMBG Segment

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast by Segment
  • 4. Revenue Forecast Discussion
  • 5. Market Share Analysis

11. EUROPE POCT SEGMENT

Europe POCT Segment

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast by Segment
  • 4. Revenue Forecast Discussion
  • 5. Market Share Analysis

12. EUROPE LAB-BASED TESTING SEGMENT

Europe Lab-based Testing Segment

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast Discussion
  • 4. Market Share Analysis
  • 5. Lab-based Testing Segment Trends
  • 6. Comparison of Lab-based Tests
  • 7. Comparison of Lab-based Tests (continued)

13. EUROPE-REGIONAL ANALYSIS

Europe-Regional Analysis

  • 1. Regional Overview
  • 2. Revenue Forecast-The United Kingdom
  • 3. UK Regulations and Reimbursements
  • 4. Revenue Forecast by Segment-The United Kingdom
  • 5. UK Revenue Forecast Discussion
  • 6. UK Revenue Forecast Discussion (continued)
  • 7. UK Revenue Forecast Discussion (continued)
  • 8. UK Revenue Forecast Discussion (continued)
  • 9. Market Impact of Top 10 Trends
  • 10. Revenue Forecast-Germany
  • 11. Germany Reimbursements and Regulations
  • 12. Revenue Forecast by Segment-Germany
  • 13. Germany Revenue Forecast Discussion
  • 14. Germany Revenue Forecast Discussion (continued)
  • 15. Market Impact of Top 10 Trends
  • 16. Revenue Forecast-France
  • 17. France Reimbursements and Regulations
  • 18. France Reimbursements and Regulations (continued)
  • 19. Revenue Forecast by Segment-France
  • 20. France Revenue Forecast Discussion
  • 21. France Revenue Forecast Discussion (continued)
  • 22. France Revenue Forecast Discussion (continued)
  • 23. Market Impact of Top 10 Trends
  • 24. Revenue Forecast-Italy
  • 25. Italy Reimbursements and Regulations
  • 26. Revenue Forecast by Segment-Italy
  • 27. Italy Revenue Forecast Discussion
  • 28. Italy Revenue Forecast Discussion (continued)
  • 29. Market Impact of Top 10 Trends
  • 30. Revenue Forecast-Spain
  • 31. Spain Reimbursements and Regulations
  • 32. Revenue Forecast by Segment-Spain
  • 33. Spain Revenue Forecast Discussion
  • 34. Spain Revenue Forecast Discussion (continued)
  • 35. Market Impact of Top 10 Trends
  • 36. Revenue Forecast-Benelux (Belgium, the Netherlands, Luxembourg)
  • 37. Benelux Reimbursements and Regulations
  • 38. Benelux Reimbursements and Regulations (continued)
  • 39. Revenue Forecast by Segment-Benelux
  • 40. Benelux Revenue Forecast Discussion
  • 41. Revenue Forecast-Scandinavia
  • 42. Scandinavia Reimbursements and Regulations
  • 43. Revenue Forecast by Segment-Scandinavia
  • 44. Scandinavia Revenue Forecast Discussion
  • 45. Market Impact of Top 10 Trends

14. KEY COMPANIES TO WATCH

Key Companies to Watch

  • 1. HemoCue
  • 2. NovioSense
  • 3. Miraculins

15. THE LAST WORD

The Last Word

  • 1. The Last Word-3 Big Predictions

16. APPENDIX

Appendix

  • 1. Additional Studies of Interest
  • 2. Additional Studies of Interest (continued)
  • 3. Methodology
  • 4. List of Exhibits
  • 5. List of Exhibits (continued)
  • 6. List of Exhibits (continued)
  • 7. List of Exhibits (continued)
  • 8. List of Exhibits (continued)
  • 9. List of Exhibits (continued)
  • 10. List of Exhibits (continued)
  • 11. List of Exhibits (continued)

List of Exhibits

  • Total Diabetes Diagnostics Market: Market Engineering Measurements, US and Europe, 2014
  • Total Diabetes Diagnostics Market: Percent Prevalence of Diabetes, Global, 2014
  • Total Diabetes Diagnostics Market: Market Segmentation, US and Europe, 2014
  • Total Diabetes Diagnostics Market: Segment Life Cycle Analysis, US and Europe, 2014
  • Total Diabetes Diagnostics Market: Percent Revenue Breakdown, US and Europe, 2014
  • Total Diabetes Diagnostics Market: Competitive Segment Analysis, US and Europe, 2014
  • Total Diabetes Diagnostics Market: Market Outlook, US and Europe, 2014 and 2024
  • Total Diabetes Diagnostics Market: Competitive Landscape, US and Europe, 2014
  • Total Diabetes Diagnostics Market: Game-changing Strategies, US and Europe, 2014
  • Total Diabetes Diagnostics Market: Top Product Analysis, US and Europe, 2014
  • Total Diabetes Diagnostics Market: Market Engineering Measurements, US and Europe, 2014
  • Total Diabetes Diagnostics Market: Revenue Forecast, US and Europe, 2011-2020
  • Total Diabetes Diagnostics Market by Segment: Percent Sales Breakdown, US and Europe, 2014
  • Total Diabetes Diagnostics Market: Percent Sales Breakdown, US and Europe, 2020
  • Total Diabetes Diagnostics Market: Revenue Forecast by Segment, US and Europe, 2011-2020
  • Diabetes Diagnostics Market: Key Market Drivers, US, 2015-2020
  • Diabetes Diagnostics Market: Key Market Restraints, US, 2015-2020
  • Diabetes Diagnostics Market: Market Engineering Measurements, US, 2014
  • Diabetes Diagnostics Market: Revenue Forecast, US, 2011-2020
  • Diabetes Diagnostics Market: Percent Sales Breakdown, US, 2014
  • Diabetes Diagnostics Market: Percent Sales Breakdown, US, 2020
  • Diabetes Diagnostics Market: Revenue Forecast by Segment, US, 2011-2020
  • SMBG Segment: Market Engineering Measurements, US, 2014
  • SMBG Segment: Revenue Forecast, US, 2011-2020
  • SMBG Segment: Revenue Forecast by Sub-Segment, US, 2011-2020
  • SMBG Segment: Percent Revenue Breakdown, US, 2014
  • SMBG Segment: Market Positions of the Leading Participants, US, 2014
  • POCT Segment: Market Engineering Measurements, US, 2014
  • POCT Segment: Revenue Forecast, US, 2011-2020
  • POCT Segment: Revenue Forecast by Sub-Segment, US, 2011-2020
  • POCT Segment: Percent Revenue Breakdown, US, 2014
  • Lab-based HbA1c Testing Segment: Market Engineering Measurements, US, 2014
  • Lab-based HbA1c Testing Segment: Revenue Forecast, US, 2011-2020
  • Lab-based Testing Segment: Percent Revenue Breakdown, US, 2014
  • Diabetes Diagnostics Market: Trends of Lab-based Tests, US, 2014
  • FPG Testing Market: Market Potential, US, 2014
  • OGTT Testing Market: Market Potential, US, 2014
  • HbA1c Testing Market: Market Potential, US, 2014
  • Microalbumin Market: Market Potential, US, 2014
  • Diabetes Diagnostics Market: Market Engineering Measurements, Europe, 2014
  • Diabetes Diagnostics Market: Revenue Forecast, Europe, 2011-2020
  • Diabetes Diagnostics Market: Revenue Forecast by Segment, Europe, 2011-2020
  • Diabetes Diagnostics Market: Percent Sales Breakdown, Europe, 2014
  • Diabetes Diagnostics Market: Percent Sales Breakdown, Europe, 2020
  • SMBG Segment: Market Engineering Measurements, Europe, 2014
  • Diabetes Diagnostics Market: SMBG Revenue Forecast, Europe, 2011-2020
  • SMBG Segment: Revenue Forecast, Europe, 2011-2020
  • SMBG Segment: Percent Revenue Breakdown, Europe, 2014
  • POCT Segment: Market Engineering Measurements, Europe, 2014
  • POCT Segment: Revenue Forecast, Europe, 2011-2020
  • POCT Segment: Revenue Forecast by Segment, Europe, 2011-2020
  • POCT segment: Percent Revenue Breakdown, Europe, 2014
  • Lab-based HbA1c Testing Segment: Market Engineering Measurements, Europe, 2014
  • Lab-based HbA1c Testing Segment: Revenue Forecast, Europe, 2011-2020
  • Lab-based Testing Segment: Percent Revenue Breakdown, Europe, 2014
  • Diabetes Diagnostics Market: Trends of Lab-based Tests, Europe, 2014
  • FPG Testing Market: Market Potential, Europe, 2014
  • OGTT Testing Market: Market Potential, Europe, 2014
  • HbA1c Testing Market: Market Potential, Europe, 2014
  • Microalbumin Market: Market Potential, Europe, 2014
  • Diabetes Diagnostics Market: Percent Sales breakdown by Region, Europe, 2014
  • Diabetes Diagnostics Market: Revenue Forecast, UK, 2011-2020
  • Diabetes Diagnostics Market: Demographic Information, UK, 2014
  • Diabetes Diagnostics Market: Revenue Forecast by Segment, UK, 2011-2020
  • Diabetes Diagnostics Market: Impact of Top 10 Trends, UK, 2014
  • Diabetes Diagnostics Market: Revenue Forecast, Germany, 2011-2020
  • Diabetes Diagnostics Market: Demographic Information, Germany, 2014
  • Diabetes Diagnostics Market: Revenue Forecast by Segment, Germany, 2011-2020
  • Diabetes Diagnostics Market: Impact of Top 10 Trends, Germany, 2014
  • Diabetes Diagnostics Market: Revenue Forecast, France, 2011-2020
  • Diabetes Diagnostics Market: Demographic Information, France, 2014
  • Diabetes Diagnostics Market: Revenue Forecast by Segment, France, 2011-2020
  • Diabetes Diagnostics Market: Impact of Top 10 Trends, France, 2014
  • Diabetes Diagnostics Market: Revenue Forecast, Italy, 2011-2020
  • Diabetes Diagnostics Market: Demographic Information, Italy, 2014
  • Diabetes Diagnostics Market: Revenue Forecast by Segment, Italy, 2011-2020
  • Diabetes Diagnostics Market: Impact of Top 10 Trends, Italy, 2014
  • Diabetes Diagnostics Market: Revenue Forecast, Spain, 2011-2020
  • Diabetes Diagnostics Market: Demographic Information, Spain, 2014
  • Diabetes Diagnostics Market: Revenue Forecast by Segment, Spain, 2011-2020
  • Diabetes Diagnostics Market: Impact of Top 10 Trends, Spain, 2014
  • Diabetes Diagnostics Market: Revenue Forecast, Benelux, 2011-2020
  • Diabetes Diagnostics Market: Demographic Information, Benelux, 2014
  • Diabetes Diagnostics Market: Demographic Information, the Netherlands, 2014
  • Diabetes Diagnostics Market: Revenue Forecast by Segment, Benelux, 2011-2020
  • Diabetes Diagnostics Market: Revenue Forecast, Scandinavia, 2011-2020
  • Diabetes Diagnostics Market: Demographic Information, Scandinavia, 2014
  • Diabetes Diagnostics Market: Revenue Forecast by Segment, Scandinavia, 2011-2020
  • Diabetes Diagnostics Market: Impact of Top 10 Trends, Benelux and Scandinavia, 2014
Back to Top